Strain selection — why the indica/sativa framework is wrong (and what to use instead)

The botanical distinction between Cannabis indica and Cannabis sativa originated in 18th-century European taxonomy of cannabis varieties from different geographic origins. Modern molecular taxonomy generally treats these as a single species (or close varieties of one species) — and importantly, virtually every commercial cannabis cultivar today is a hybrid. The "pure indica" or "pure sativa" labels are essentially marketing.

The bigger problem: even when there's a real botanical distinction, it doesn't reliably predict effects.

McPartland & Russo (2014) reviewed the indica/sativa effect-prediction literature and found weak evidence for the consumer-facing claims. Lewis-Bakker et al. (2017) chemically analyzed cultivars labeled "indica" vs "sativa" and found that 80%+ of the variance in chemical profile (cannabinoids and terpenes) didn't track the indica/sativa labels.

So if you've felt frustrated that "the indica didn't make me sleepy" or "the sativa wasn't actually energizing" — that's a coherent observation. The framework isn't predictive.

Three things, roughly in order of importance:

1. Cannabinoid ratio. THC:CBD ratio is the single biggest determinant of effect character. High-THC, low-CBD: psychoactive, potentially anxiogenic at high doses. THC:CBD around 1:1: psychoactive but smoothed; CBD modulates THC adverse effects (Englund 2013). High-CBD, low-THC: minimal psychoactivity, potentially anxiolytic, popular for daytime use.

2. Terpene profile. As covered in our terpenes article: myrcene + linalool dominant = sedating. Limonene + pinene dominant = uplifting/focused. Caryophyllene-rich = anti-inflammatory + analgesic. The terpene-driven framework predicts effect significantly better than indica/sativa.

3. Total dose. A "sativa" at 25 mg THC will produce more cognitive disruption than an "indica" at 5 mg. Dose dominates many of the effects users attribute to strain type.

Ignore (or weight much less):

• Indica/sativa labels
• Strain names (have you noticed how many cultivars share names but differ chemically?)
• "Hybrid" without further qualification
• Strain-naming aesthetics ("OG", "Cookies", "Cake" don't tell you much)

A reputable retail label (legal-state dispensary product) should show:

• Total THC + Total CBD percentages (these are cannabinoids after decarboxylation)
• Optional: profile of minor cannabinoids
• Optional: top 6-10 terpenes with concentration

A high-quality label additionally shows:

• Test date + lab name
• Batch number
• Harvest date
• Cultivation method (indoor/outdoor/greenhouse)

If a label has only "THC: 22%" with no other information, you're paying for branded packaging more than for product knowledge.

For terpenes specifically, here are useful patterns:

| Goal | Look for | |------|----------| | Sleep | High myrcene + linalool | | Daytime focus | High limonene + pinene | | Pain / inflammation | High caryophyllene | | Anxiety reduction | High limonene + linalool, balanced THC:CBD | | Creative work | High pinene, moderate THC |

These are starting points, not prescriptions. Individual response varies.

If you're a serious consumer (or thinking about becoming one), it's worth keeping notes. The variation between cultivars and between batches of the same cultivar is significant; relying on memory alone leads to repeated unsatisfying purchases.

A simple log:

• Date + dispensary + cultivar + batch number
• Cannabinoid + terpene profile (from label or COA)
• Dose taken
• Subjective effect 1 hour in, 3 hours in, next day
• Whether you'd repurchase

After 5-10 entries, patterns emerge. You discover that "any product with myrcene >40% works for sleep" or "I tolerate THC much better when CBD is at 30%+ relative" or "high-pinene actually does prevent the brain fog I get from other cultivars."

This is the boring, evidence-based way to get good at cannabis consumption. It's how serious connoisseurs of any consumable (wine, coffee, tea) operate. Cannabis culture mostly lacks this discipline; you can outperform 95% of consumers by adopting it.